Authors showed that >15% increase of Gal-3 concentrations between measurements was associated with a 50% higher risk for subsequent HF morbidity and mortality, independently of age, sex, diabetes mellitus, left ventricular ejection fraction, renal function, HF medication, and NT-proBNP (p = 0.001) [28]. The gene discussed is LGALS3; the disease is diabetes mellitus.